STN: 103914
Proper Name: Influenza Vaccine
Tradename: Fluzone Quadrivalent, Fluzone High-Dose Quadrivalent, Fluzone, Intradermal Quadrivalent, Fluzone Quadrivalent Southern Hemisphere
Manufacturer: Sanofi Pasteur Inc.
Indication:
- Fluzone High-Dose Quadrivalent: For active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.
- Fluzone Quadrivalent: For active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. It is approved for use in persons 6 months of age and older.
- Fluzone Intradermal Quadrivalent: For active immunization of persons 18 through 64 years of age for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.
- Fluzone Quadrivalent Southern Hemisphere: for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. (1) It is approved for use in persons 6 months of age and older.
